Damloran Pharmaceutical (XTEH:DAML1) Net Margin %: 0.00% (As of . 20)


XTEH:DAML1 Damloran Pharmaceutical XTEH:DAML1
27 GF Score
Price IRR10,100.00
View Full Analysis

What is Damloran Pharmaceutical Net Margin %?

Damloran Pharmaceutical XTEH:DAML1 27 Net Margin % is 0.00% as of . 20. GuruFocus rates XTEH:DAML1 with a GF Score™ of 27/100.

Net margin is calculated as Net Income divided by its Revenue. Damloran Pharmaceutical's Net Income for the six months ended in . 20 was IRR0.00 Mil. Damloran Pharmaceutical's Revenue for the six months ended in . 20 was IRR0.00 Mil. Therefore, Damloran Pharmaceutical's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Damloran Pharmaceutical's Net Margin % or its related term are showing as below:


XTEH:DAML1's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.58
* Ranked among companies with meaningful Net Margin % only.

Damloran Pharmaceutical  (XTEH:DAML1) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Damloran Pharmaceutical Net Margin % Related Terms

Damloran Pharmaceutical Net Margin % Historical Data

* Premium members only.

The historical data trend for Damloran Pharmaceutical's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Damloran Pharmaceutical Net Margin % Chart

Damloran Pharmaceutical Annual Data
Trend
Net Margin %

Damloran Pharmaceutical Semi-Annual Data
Net Margin %

XTEH:DAML1 vs IMNPQ: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Damloran Pharmaceutical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Damloran Pharmaceutical Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Damloran Pharmaceutical's Net Margin % distribution charts can be found below:

* The bar in red indicates where Damloran Pharmaceutical's Net Margin % falls into.


XTEH:DAML1
27GF Score
Damloran Pharmaceutical XTEH:DAML1
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Damloran Pharmaceutical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Damloran Pharmaceutical's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Damloran Pharmaceutical's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Damloran Pharmaceutical (XTEH:DAML1) has a Net Margin % of 0.00% as of . 20. Net margin is the ratio of total net income to net sales. View historical data on Damloran Pharmaceutical and its competitors.
Is Damloran Pharmaceutical's Net Margin % too high?
Damloran Pharmaceutical's current Net Margin % is 0.00%. Overall, Damloran Pharmaceutical has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Damloran Pharmaceutical's Net Margin % compare to IMNPQ?
Damloran Pharmaceutical's Net Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Net Margin % is 5.58. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.58, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Damloran Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Damloran Pharmaceutical's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Damloran Pharmaceutical stock overvalued right now?
Damloran Pharmaceutical (XTEH:DAML1) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Damloran Pharmaceutical's overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Damloran Pharmaceutical (XTEH:DAML1), the current Net Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Damloran Pharmaceutical Business Description

Address No.4, Parvin Alley, West Fatemi Avenue, Tehran, IRN
Damloran Pharmaceutical manufactures and markets livestock and poultry pharmaceuticals. The Company offers animal health products to protect and improve health and hygiene of society to treat and to enhance the quality of animals' life.
27GF Score

Get the complete analysis for XTEH:DAML1

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

IRR10,100.00
Price